Showing results (31-40 of 158) with videos related to

Sort By:
Pageof 16
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|July 11, 2013
Neural effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253Emma J Rose, Derek W Morris, April Hargreaves, et al.
Genes, Brain, and Behavior|August 7, 2019
Beyond C4: Analysis of the complement gene pathway shows enrichment for IQ in patients with psychotic disorders and healthy controlsJessica F Holland, Donna Cosgrove, Laura Whitton, et al.
Bipolar Disorders|October 2, 2012
Social cognition in bipolar disorder versus schizophrenia: comparability in mental state decoding deficitsGary Donohoe, Aoife Duignan, April Hargreaves, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|September 12, 2020
Effects of complement gene-set polygenic risk score on brain volume and cortical measures in patients with psychotic disorders and healthy controlsJessica F Holland, Donna Cosgrove, Laura Whitton, et al.
Journal of the International Neuropsychological Society : JINS|October 27, 2006
Do antisaccade deficits in schizophrenia provide evidence of a specific inhibitory function?Gary Donohoe, Richard Reilly, Sarah Clarke, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|July 22, 2014
The miR-137 schizophrenia susceptibility variant rs1625579 does not predict variability in brain volume in a sample of schizophrenic patients and healthy individualsEmma J Rose, Derek W Morris, Ciara Fahey, et al.
Schizophrenia Research|May 13, 2006
Neurocognition and suicidal behaviour in an Irish population with major psychotic disordersJeanne-Marie Nangle, Sarah Clarke, Derek W Morris, et al.
Pageof 16